{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:35:39Z","timestamp":1787070939478,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>We assessed the preliminary efficacy and toxicity of intrapleural instillation of nivolumab in patients with large pleural effusion. Patients with metastatic cancers who have a large volume of pleural effusion and required evacuation were eligible. Thoracentesis followed by nivolumab (40 mg, single intrapleural instillation) was performed. The primary endpoint was 3-month recurrence-free survival. A total of 13 patients were enrolled. The study was terminated after stage 1 as no efficacy was observed; 7 patients (54%) had a recurrence of pleural effusion at 3 months. Thirteen (100%) patients had no recurrence, dyspnea, or cough within 1 month, and the median time to recurrence was 1.9 months (95% confidence interval [CI], 1.35\u20132.5). No adverse events were identified. We concluded that a single intrapleural instillation of the nivolumab at 40 mg was ineffective and well-tolerated in cancer patients with pleural effusion.<\/jats:p>","DOI":"10.4103\/jcrt.jcrt_739_22","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T17:53:29Z","timestamp":1719510809000},"page":"1036-1038","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Intrapleural nivolumab in cancer patients with pleural effusion"],"prefix":"10.4103","volume":"20","author":[{"given":"Ilya","family":"Tsimafeyeu","sequence":"first","affiliation":[{"name":"Bureau of Cancer Research, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Goutnik","sequence":"additional","affiliation":[{"name":"Medicine 24\/7 Clinic, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Shrainer","sequence":"additional","affiliation":[{"name":"First City Hospital, Moscow, Russia"},{"name":"Medscan Diagnostic Center, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav","family":"Kosyrev","sequence":"additional","affiliation":[{"name":"Institute of Oncology, Hadassah Medical Moscow, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Bondarenko","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow State Medical University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Utyashev","sequence":"additional","affiliation":[{"name":"Institute of Oncology, Hadassah Medical Moscow, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3390\/medicina55080490","article-title":"Malignant pleural effusion and its current management:A review","volume":"55","author":"Skok","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"R2-20241021","doi-asserted-by":"crossref","first-page":"659983","DOI":"10.3389\/fsurg.2021.659983","article-title":"Targeted therapy followed by salvage surgery and adjuvant therapy:A promising therapy for lung cancer with malignant pleural effusion from a case report","volume":"8","author":"Deng","year":"2021","journal-title":"Front Surg"},{"key":"R3-20241021","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1183\/09031936.93.02040366","article-title":"Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a post-mortem series","volume":"2","author":"Rodr\u00eeguez-Panadero","year":"1989","journal-title":"Eur Respir J"},{"issue":"(Suppl 2)","key":"R4-20241021","first-page":"ii32","article-title":"Management of a malignant pleural effusion:British thoracic society pleural disease guideline 2010","volume":"65","author":"Roberts","year":"2010","journal-title":"Thorax"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. An official ATS\/STS\/STR clinical practice guideline","volume":"198","author":"Feller-Kopman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"(Suppl 7)","key":"R6-20241021","first-page":"S1428","article-title":"42P-Pleural effusion is a negative prognostic factor for immunotherapy in non small cell lung cancer (NSCLC):The PLUIE study","volume":"31","author":"Epaillard","year":"2020","journal-title":"Ann Oncol"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"672747","DOI":"10.3389\/fonc.2021.672747","article-title":"Malignant pleural effusions-A window into local anti-tumor T cell immunity?","volume":"11","author":"Principe","year":"2021","journal-title":"Front Oncol"},{"key":"R8-20241021","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1378\/chest.126.6.1764","article-title":"Pleural manometry:Technique and clinical implications","volume":"126","author":"Doelken","year":"2004","journal-title":"Chest"},{"key":"R9-20241021","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S2213-2600(19)30373-X","article-title":"Malignant pleural effusion management:Keeping the flood gates shut","volume":"8","author":"Walker","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R10-20241021","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s40425-019-0590-4","article-title":"Treatment of malignant pleural effusions:The case for localized immunotherapy","volume":"7","author":"Donnenberg","year":"2019","journal-title":"J Immunother Cancer"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s002620050407","article-title":"Intrapleural instillation of interferon gamma in patients with malignant pleurisy due to lung cancer","volume":"45","author":"Yanagawa","year":"1997","journal-title":"Cancer Immunol Immunother"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1200\/JCO.2004.09.164","article-title":"Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions","volume":"22","author":"Sartori","year":"2004","journal-title":"J Clin Oncol"},{"key":"R13-20241021","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/bjc.1995.501","article-title":"Intrapleural administration of interleukin 2 in pleural mesothelioma:A phase I-II study","volume":"72","author":"Goey","year":"1995","journal-title":"Br J Cancer"},{"key":"R14-20241021","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0169-5002(00)00192-6","article-title":"Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion:Results of a phase II study on 31 consecutive patients","volume":"31","author":"Castagneto","year":"2001","journal-title":"Lung Cancer"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_739_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:39:16Z","timestamp":1787067556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_739_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_739_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,6]]},"assertion":[{"value":"2022-03-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}